Michael Lidsky, Surgical Oncologist and Hepatopancreatobiliary Surgeon at Duke Surgery, shared a post by Cathy Eng, VICC Associate Director, Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, adding:
“Had a blast sparring with Nipun Merchant on the topic of liver directed therapy for CRLM. Great review of evidence including knowledge gaps, highlighting how far we still have to come. Modern-day trials like EA2222 are essential to determine the role of HAI.”
“Looking forward to Great Debates Miami in March 2026 and to have these two it out again! Michael Lidsky, Nipun Merchan! They took the task at hand and had a great debate. Gold stars to both of them.”